Valeant seeks to become top 5 pharmaceutical company -CEO

Tue Jan 7, 2014 8:53am EST

Jan 7 (Reuters) - Valeant Pharmaceuticals International Inc aims to crack the top-five ranks of drug companies by market capitalization by the end of 2016, Chief Executive Michael Pearson said on Tuesday.

Montreal, Quebec-based Valeant, which has a market cap of about $38.4 billion and sits among the top 15 pharmaceutical companies by that measure, would need to reach about $150 billion in market cap to crack the top five, Pearson said on a call with analysts and investors.

A couple walks along the rough surf during sunset at Oahu's North Shore, December 26, 2013. REUTERS/Kevin Lamarque

Find your dream retirement town

Florida? Hawaii? Reuters has teamed up with Zillow to give you the power to customize a list of your best places to retire.  Video | Full Article